Business Context and Reporting Period
This Form 8-K is filed by Intelligent Bio Solutions Inc. (INBS) on February 16, 2024. The report addresses the company's compliance status with The Nasdaq Stock Market LLC listing requirements, specifically regarding minimum bid price and stockholders' equity.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or debt metrics. However, it references historical equity data:
- Stockholders' Equity (Sept 30, 2023): $1,236,558 (reported in prior 10-Q, below the $2.5M requirement).
- Stockholders' Equity (Oct 31, 2023): $4,240,629 (pro forma, following a public offering on October 4, 2023).
- Stock Price: Closed at $1.00 or greater for 11 consecutive business days (Jan 29, 2024 – Feb 12, 2024).
Material Changes
The primary material change is the resolution of two delisting risks:
- Minimum Bid Price: The company regained compliance with Nasdaq Listing Rule 5550(a)(2) after its stock price remained at or above $1.00 for 11 consecutive days.
- Stockholders' Equity: Nasdaq confirmed compliance with Listing Rule 5550(b)(1) following the filing of the Form 10-Q for the period ended December 31, 2023, which evidenced equity levels meeting the $2.5 million threshold.
Outlook, Risks, and Management Commentary
Management confirmed via press release that Nasdaq considers both compliance matters closed. The company is no longer subject to immediate delisting proceedings regarding these specific rules. The filing notes that prior to the October 2023 offering, the company did not meet alternative compliance standards (market value of $35 million or net income of $500,000).
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for any additional context.
- Review the upcoming Form 10-Q for the period ended December 31, 2023, to confirm the audited stockholders' equity figure.
- Monitor the stock price to ensure it remains above the $1.00 minimum bid price to avoid future non-compliance notices.
- Check for any other outstanding Nasdaq compliance issues not addressed in this filing.